Human Liver Tissue MicroArray (Cancer)

Images

 
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 01. Skin, Metastatic Hepatocellular Carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 02. liver Hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 03. liver Hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 04. Skin Metastic Hepatocellular Carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 05. chest wall metastic Hepatocellular Carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 06. Lumbar vertebra Metastic Hepatocellular Carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 07. Liver Hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 08. Bile duct hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 09. colon metatastic hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 10. Bile duct hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 11. Liver hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 2. Lung Metastatic Hepatocellular Carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 13. Lymph node metastatic hepatocellular Carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 14. Liver, hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 15. Liver, hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 16. Neck metastatic hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 17. Liver combined hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 18. Femur, metastatic hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 19. Liver hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 20. Lung, metastatic hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 21. Lung, metastatic hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 22. Liver hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 23. Liver, hepatocellular carcinoma M/D
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 24. Liver hepatocellular carcinoma, P/D
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 25. Liver, hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 26. Liver hepatocellular carcinoma, Well differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 27. Liver hepatocellular carcinoma, Well differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 28. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 29. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 30. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 31. Liver hepatocellular carcinoma M/D
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 32. Liver, hepatocellular carcinoma, W/D
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 33. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 34. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 35. Omentum metastic hepatocellular
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 37. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 38. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 39. Liver hepatocellular carcinoma, poorly differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 40. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 41. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 42. Liver hepatocellular carcinoma, moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 44. Liver hepatocellular carcinoma, Moderately differentiatied
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 45. Liver hepatocellular carcinoma, Poorly differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 46. Liver hepatocellular carcinoma, moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 47. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 48. Liver hepatocellular carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 49. Adrenal gland metastatic hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 50. Liver Hepatocellular carcinoma M/D
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 51. Liver hepatocellular carcinoma, moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 52. Liver, hepatocellular carcinoma
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 53. Liver, hepatocellular carcinoma, well differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 54. Liver, hepatocellular carcinoma, well differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 55. Hepatocellular carcinoma, moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 56.Liver hepatocellular carcinoma, moderately differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 57.Liver hepatocellular carcinoma, poorly differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 59.Liver hepatocellular carcinoma, poorly differentiated
Hematoxylin & Eosin Stain: Human Liver Tissue MicroArray (Cancer) [NBP2-30271] - 58.Liver hepatocellular carcinoma, moderately differentiated

Product Details

Summary
Reactivity HuSpecies Glossary
Applications IHC-P

Order Details

Human Liver Tissue MicroArray (Cancer) Summary

Description
Microarray Panel:
Liver cancer
No. of samples 59
No. of patients 59
Core diameter 2.0 mm
Format:Formalin Fixed
Section thickness 4 micrometer
Core#
No.
Age Sex Organ Diagnosis pTNM Stage No. of CSN4# Tissue
type
Image
1 53 F Skin metastatic hepatocellular carcinoma TxNxM1 IVB . 6
2 57 M Liver hepatocellular carcinoma T3aN0M0 IIIA 104 6
3 41 M Liver hepatocellular carcinoma T3aN0M0 IIIA . 6
4 45 M Skin metastatic hepatocellular carcinoma TxNxM1 IVB . 6
5 54 F Chest wall metastatic hepatocellular carcinoma TxNxM1 IVB . 6
6 40 M Lumbar vertebra metastatic hepatocellular carcinoma TxNxM1 IVB . 6
7 52 M Liver hepatocellular carcinoma T3aN0M0 IIIA 112 6
8 43 M Bile duct hepatocellular carcinoma T4NxM0 IIIC . 6
9 51 M Colon metastatic hepatocellular carcinoma TxNxM1 IVB . 6
10 49 M Bile duct hepatocellular carcinoma T4NxM0 IIIC . 6
11 56 M Liver hepatocellular carcinoma T1N0M0 I . 6
12 56 F Lung metastatic hepatocellular carcinoma TxNxM1 IVB . 6
13 40 M Lymph node metastatic hepatocellular carcinoma T3aN1M0 IVA . 6
14 37 M Liver hepatocellular carcinoma T4NxM1 IVB 131 6
15 75 M Liver hepatocellular carcinoma T2N0M0 II 132 6
16 37 M Neck metastatic hepatocellular carcinoma TxNxM1 IVB . 6
17 32 M Liver combined hepatocellular carcinoma & cholangiocarcinoma T3aN0M0 IIIA 133 6
18 50 M Femur metastatic hepatocellular carcinoma TxNxM1 IVB . 6
19 57 M Liver hepatocellular carcinoma T3aN0M0 IIIA 134 6
20 62 M Lung metastatic hepatocellular carcinoma TxNxM1 IVB . 6
21 61 M Lung metastatic hepatocellular carcinoma TxNxM1 IVB . 6
22 65 M Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I 135 6
23 64 M Liver hepatocellular carcinoma, moderately differentiated T3bN0M0 IIIB . 6
24 65 M Liver hepatocellular carcinoma, poorly differentiated T3aN0M0 IIIA 137 6
25 72 M Liver hepatocellular carcinoma, well differentiated & poorly differentiated T2N0M0 II 138 6
26 58 F Liver hepatocellular carcinoma, well differentiated T2N0M0 II 139 6
27 52 M Liver hepatocellular carcinoma, well differentiated T2N0M0 II 140 6
28 40 M Liver hepatocellular carcinoma, moderately differentiated T2N0M0 II 141 6
29 53 F Liver hepatocellular carcinoma, moderately differentiated T3bN0M0 IIIB 142 6
30 67 M Liver hepatocellular carcinoma, moderately differentiated T2N0M0 II 143 6
31 58 F Liver hepatocellular carcinoma, moderately differentiated T3aN0M0 IIIA . 6
32 20 M Liver hepatocellular carcinoma, well differentiated T4N0M0 IIIC . 6
33 48 M Liver hepatocellular carcinoma, moderately differentiated T2N0M0 II . 6
34 47 M Liver hepatocellular carcinoma T1N0M0 I 144 6
35 35 M Omentum metastatic hepatocellular carcinoma TxNxM1 IV . 6
36 69 F Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I . 6
37 46 M Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I . 6
38 63 F Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I 146 6
39 60 F Liver hepatocellular carcinoma, poorly differentiated T1N0M0 I 147 6
40 62 M Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I 148 6
41 52 M Liver hepatocellular carcinoma, moderately differentiated T2N0M0 II . 6
42 66 F Liver hepatocellular carcinoma, moderately differentiated T2N0M0 II 149 6
43 65 F Liver hepatocellular carcinoma, well differentiated T1N0M0 I 150 6
44 64 M Liver hepatocellular carcinoma, moderately differentiated T3bN0M0 IIIB . 6
45 59 M Liver hepatocellular carcinoma, poorly differentiated T3bN0M0 IIIB . 6
46 64 M Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I 151 6
47 54 M Liver hepatocellular carcinoma, moderately differentiated T3bN0M0 IIIB 152 6
48 65 F Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I 153 6
49 60 M Adrenal gland metastatic hepatocellular carcinoma TxNxM1 IVB . 6
50 44 M Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I . 6
51 41 M Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I . 6
52 51 M Liver hepatocellular carcinoma T1N0M0 I 154 6
53 55 M Liver hepatocellular carcinoma, well differentiated T1N0M0 I . 6
54 57 F Liver hepatocellular carcinoma, well differentiated T1N0M0 I 156 6
55 57 M Liver hepatocellular carcinoma, moderately differentiated T3bN0M0 IIIB 157 6
56 43 M Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I . 6
57 50 M Liver hepatocellular carcinoma, poorly differentiated T1N0M0 I 158 6
58 43 M Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I 159 6
59 60 F Liver hepatocellular carcinoma, poorly differentiated T4N0M0 IIIC . 6
60 . . Carbon . . . . .


Applications/Dilutions

Publications
Read Publications using NBP2-30271.

Reactivity Notes

Human

Packaging, Storage & Formulations

Storage
Store at 4C. Do not freeze.

Details for Liver

Type
Tissue
Tissue Condition
Cancer

Alternate Names for Human Liver Tissue MicroArray (Cancer)

  • Liver lysate
  • liver lysates
  • Liver

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Tissue Micro Arrays are guaranteed for 1 year from date of receipt.

Publications for Liver Tissue Micro Array (NBP2-30271)(7)

We have publications tested in 1 application: IHC-P.


Filter By Application
IHC-P
(6)
All Applications
Filter By Species
All Species
Showing Publications 1 - 7 of 7.
Publications using NBP2-30271 Applications Species
Rajasekaran D, Jariwala N, Mendoza RG et al. Staphylococcal nuclease and tudor domain containing 1 (SND1) promotes hepatocarcinogenesis by inhibiting monoglyceride lipase (MGLL). J. Biol. Chem. 2016 Mar 20 [PMID: 26997225] (IHC-P) IHC-P
Tavallai M, Hamed HA, Roberts JL et al. Nexavar/Stivarga and Viagra Interact to Kill Tumor Cells J. Cell. Physiol. 2015 Feb 20 [PMID: 25704960] (IHC-P)

Details:
Human Liver Tissue Microarray (Cancer) (Imgenex IMH-318) was used in IHC-P immunostaining application for the analysis of PDE5 / PDE5A and PDGFR using a mixture of PDGF R alpha and PDGF R beta antibodies. The immunoassay implicated an antigen retrieval steps and the the data is shown in Figure 2.
IHC-P
Yoo BK, Santhekadur PK, Gredler R et al. Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma. Hepatology. 2011 May [PMID: 21520169] (IHC-P)

Details:
Liver cancer-metastasis normal (IMH-360) and matching liver cancer (IMH-318). IHC (paraffin): Tissues were stained with SND1 antibody, Fig 6C.
IHC-P
Yoo BK, Emdad L, Gredler R et al. Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinoma. Proc Natl Acad Sci U S A. 2010 May 4 [PMID: 20404171] (IHC-P)

Details:
IMH-360: (liver cancer-metastasis-normal tissue microarray): IHC (paraffin), the tissue microarray was probed with LSF (Late SV40 Factor), Fig 1B.
IHC-P
Chaerkady R, Thuluvath PJ, Kim MS et al. O Labeling for a Quantitative Proteomic Analysis of Glycoproteins in Hepatocellular Carcinoma. Clin Proteomics. 2008 Jul 18 [PMID: 20357908]
Yoo BK, Emdad L, Su ZZ et al. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest. 2009 Mar [PMID: 19221438] (IHC-P)

Details:
Liver cancer tissue microarray (IMH-318), Liver cancer metastasis/normal tissue micro array (IMH-360). IHC (paraffin): Comparison of expression of AEG1, LEF1, TFCP2, DPYD, IGFBP7 proteins in normal liver and matched liver cancer tissue microarrays (IMH-318 & IMH-360), Fig 5.
IHC-P
Chaerkady R, Harsha HC, Nalli A et al. A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma. J Proteome Res. 2008 Oct [PMID: 18715028] (IHC-P)

Details:
IHC (paraffin): Myeloid-asscociated differentiation marker/MYADM (IMG-5908A) was used to label liver cancer microarray (IMH-318) and liver, non-neoplastic matching microarray (IMH-342), Fig 4 & 5.
IHC-P

Reviews for Liver Tissue Micro Array (NBP2-30271) (0)

There are no reviews for Liver Tissue Micro Array (NBP2-30271). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
  • 1st to review with an image -- $50/€35/£30/$50 CAD/¥300 Yuan/¥5000 Yen

Product General Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs for Liver Tissue Micro Array (NBP2-30271) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Additional Liver Products

Blogs on Liver.

Signalling Advances in Adiponectin Antibody Research
Adiponectin is an adipocytokine protein that positively regulates metabolism of lipids and glucose by suppressing glucose production from the liver, stimulating insulin sensitivity, and increasing the rate of fatty acid oxidation and glucose uptake. I...  Read full blog post.

Customers Who Bought This Also Bought

Contact Information

Product PDFs

Review this Product

Be the first to review our Human Liver Tissue MicroArray (Cancer) and receive a gift card or discount.